Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRCP | P42785 | 12/20 | 0.42 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.35 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.35 |
| ▸ | AADAT | Q8N5Z0 | 1/20 | 0.34 |
| ▸ | HCRTR1 | O43613 | 2/20 | 0.34 |
| ▸ | HCRTR2 | O43614 | 2/20 | 0.34 |
| ▸ | CPT1A | P50416 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1747514 | 0.97 | PRCP (0.45) | PRCPOPRM1OPRD1HCRTR1HCRTR2 | |
| SCHEMBL1746051 | 0.85 | PRCP (0.47) | PRCPAADAT | |
| SCHEMBL3343955 | 0.85 | PRCP (0.47) | PRCPOPRM1OPRD1AADATHCRTR1 | |
| SCHEMBL1745859 | 0.84 | PRCP (0.41) | PRCPHCRTR1HCRTR2 | |
| SCHEMBL1747512 | 0.82 | PRCP (0.49) | PRCPOPRM1OPRD1 | |
| SCHEMBL12174997 | 0.82 | PRCP (0.53) | PRCPOPRM1OPRD1HCRTR1HCRTR2 | |
| SCHEMBL3347973 | 0.82 | PRCP (0.52) | PRCPOPRM1OPRD1HCRTR1HCRTR2 | |
| SCHEMBL12175268 | 0.81 | PRCP (0.54) | PRCPOPRM1OPRD1 | |
| SCHEMBL1747547 | 0.80 | PRCP (0.45) | PRCPOPRM1OPRD1 | |
| SCHEMBL13748216 | 0.80 | PRCP (0.57) | PRCPOPRM1OPRD1HCRTR1HCRTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2385048-A1 | Hepatitis C virus inhibitors | Bristol-Myers Squibb Company (US) | 2011-11-09 | — | — | EP | disclosed |
| US-20110252687-A1 | Canting Vertical Fore Grip with Bipod | GRIP POD SYSTEMS, LLC | 2011-10-20 | — | — | US | disclosed |